0000939767-19-000179.txt : 20191004 0000939767-19-000179.hdr.sgml : 20191004 20191004200239 ACCESSION NUMBER: 0000939767-19-000179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191002 FILED AS OF DATE: 20191004 DATE AS OF CHANGE: 20191004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORRISSEY MICHAEL CENTRAL INDEX KEY: 0001202096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 191139500 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL M DATE OF NAME CHANGE: 20030512 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL R DATE OF NAME CHANGE: 20021029 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0103 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_157023373638520.xml FORM 4 X0306 4 2019-10-02 0 0000939767 EXELIXIS, INC. EXEL 0001202096 MORRISSEY MICHAEL C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 1 1 0 0 President and CEO Common Stock 2019-10-02 4 M 0 35409 7.18 A 231513 D Common Stock 2019-10-02 4 S 0 26364 17.66 D 205149 D Common Stock 193998 I By Trust Common Stock 17728 I By 401(k) Option (right to buy) 7.18 2019-10-02 4 M 0 35409 0 D 2010-12-09 2019-12-08 Common Stock 35409.0 0 D Includes 102,394 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2019. The shares were sold to cover the exercise price, tax withholding obligation, broker commission and fees for the exercised stock options. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.47 to $17.95. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of October 2, 2019. The option, representing the right to purchase a total of 300,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 9, 2013. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2019-10-04